Trials / Terminated
TerminatedNCT02067390
Urinary KIM-1 After Vancomycin or Linezolid Administration
Novel Urinary Biomarkers in the Detection of Vancomycin Associated Renal Injury
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 5 (actual)
- Sponsor
- Midwestern University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Acute renal injury is a common complication of critical illness. Drug induced renal insult compounds the degree of injury in many patients, and a great deal of research has focused on prevention of this complication. Traditional biomarkers of renal injury like serum creatinine and blood urea nitrogen content fail to consistently predict harm among patients at risk. Kidney Injury Molecule 1 (KIM-1) will be studied as a biomarker of renal injury.
Detailed description
see above
Conditions
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2019-05-01
- Completion
- 2019-05-01
- First posted
- 2014-02-20
- Last updated
- 2020-02-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02067390. Inclusion in this directory is not an endorsement.